Study on the curative effect of Atorvastatin combined with Telmisartan on Idiopathic paroxysmal atrial fibrillation
10.3760/cma.j.issn.1008-6706.2012.02.008
- VernacularTitle:阿托伐他汀联合替米沙坦治疗特发性阵发性心房颤动
- Author:
Shaofeng CHEN
;
Weishao AN
;
Shenglong XUE
;
Shangmiao XU
;
Keqiang LIAO
;
Jundao WANG
- Publication Type:Journal Article
- Keywords:
Atrial fibrillation;
Atorvastatin;
Telmisartan;
C-reactive protein
- From:
Chinese Journal of Primary Medicine and Pharmacy
2012;19(2):177-178
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical efficacy of Telmisartan combined with Atorvastatin in treating patients with idiopathic paroxysmal atrial fibrillation(IPAF).Methods 70 cases of IPAF were randomly divided into study group(given treatment of Telmisartan combined with Atorvastatin)and control group(given treatment of Telmisartan),35 cases in each group,all patients got 2 years follow-up visit.The change of CRP and the arrhythmia recurrence were observed after treatment.Results After surgery,patients were better than before,but the efficiency in study group was significantly higher than control group(88.6％ vs 68.6％,P ＜0.05);CRP of the two groups were significantly reduced after treatment,two groups have significant difference(P ＜ 0.05).Conclusion Curative effect of atorvastatin combined with telmisartan on IPAF is better than that of telmisartan treatment and clinical implementation should be promoted.
